130 related articles for article (PubMed ID: 19395394)
1. Short-term outcomes following intrauterine transfusion in Scotland.
McGlone L; Simpson JH; Scott-Lang C; Cameron AD; Brennand J
Arch Dis Child Fetal Neonatal Ed; 2011 Jan; 96(1):F69-70. PubMed ID: 19395394
[TBL] [Abstract][Full Text] [Related]
2. Pediatric outcome in Rhesus hemolytic disease treated with and without intrauterine transfusion.
De Boer IP; Zeestraten EC; Lopriore E; van Kamp IL; Kanhai HH; Walther FJ
Am J Obstet Gynecol; 2008 Jan; 198(1):54.e1-4. PubMed ID: 18166305
[TBL] [Abstract][Full Text] [Related]
3. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
[TBL] [Abstract][Full Text] [Related]
4. Relationship between obstetric history and Rh(D) alloimmunization severity.
Lobato G; Soncini CS
Arch Gynecol Obstet; 2008 Mar; 277(3):245-8. PubMed ID: 17763861
[TBL] [Abstract][Full Text] [Related]
5. [Management of severe feto-maternal anti-D allo-immunizations. Value of exchange transfusions in utero].
Vanlieferinghen P; Lemery D; Storme B; Raynaud EJ
Ann Pediatr (Paris); 1988 Feb; 35(2):103-8. PubMed ID: 3129976
[No Abstract] [Full Text] [Related]
6. [Intrauterine blood transfusion in severe erythrocyte stimulation. A necessary intervention but not without risks].
Engkvist F; Wåhlin M; Axelsson O
Lakartidningen; 2008 Nov 12-18; 105(46):3329-33. PubMed ID: 19062624
[No Abstract] [Full Text] [Related]
7. Early intrauterine transfusion in severe red blood cell alloimmunization.
Yinon Y; Visser J; Kelly EN; Windrim R; Amsalem H; Seaward PG; Ryan G
Ultrasound Obstet Gynecol; 2010 Nov; 36(5):601-6. PubMed ID: 20509139
[TBL] [Abstract][Full Text] [Related]
8. [Anaylsis of 29 cases of severe Rhesus isoimmunization requiring artificial ventilation (1971-1973)].
Couchard M; Marion JP; Bomsel F; Relier JP; Toubas P; Sender A; Maigret P
Ann Pediatr (Paris); 1976 Nov; 23(11):713-21. PubMed ID: 16106880
[No Abstract] [Full Text] [Related]
9. Advantages of larger volume, less frequent intrauterine red blood cell transfusions for maternal red cell alloimmunization.
Inglis SR; Lysikiewicz A; Sonnenblick AL; Streltzoff JL; Bussel JB; Chervenak FA
Am J Perinatol; 1996 Jan; 13(1):27-33. PubMed ID: 8645382
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound-guided fetal intravascular transfusion in a case of severe rhesus isoimmunization.
Piiroinen O; Erkkola R; Grönroos M
Ann Chir Gynaecol Suppl; 1987; 202():5-7. PubMed ID: 2444147
[TBL] [Abstract][Full Text] [Related]
11. Introduction of a programme for intravascular transfusions at severe rhesus isoimmunization.
Westgren M; Jabbar F; Larsen JF; Rahman F; Selbing A; Stangenberg M
J Perinat Med; 1988; 16(5-6):417-22. PubMed ID: 3149303
[TBL] [Abstract][Full Text] [Related]
12. Intrauterine transfusion for rhesus alloimmunization elevates fetal beta2-microglobulin levels.
Radunovic N; Kuczynski E; Funai EF; Nastic D; Di Renzo GC; Lockwood CJ
J Matern Fetal Neonatal Med; 2003 Apr; 13(4):246-9. PubMed ID: 12854925
[TBL] [Abstract][Full Text] [Related]
13. [Echographic criteria for predicting the pregnancy outcome after intrauterine transfusions in rhesus incompatibility].
Vasileva Iu
Akush Ginekol (Sofiia); 1988; 27(6):35-8. PubMed ID: 3149872
[No Abstract] [Full Text] [Related]
14. Intrauterine fetal transfusion.
Mirghani HH; Weerasinghe S; Al-Awar S; Hamud OA
Saudi Med J; 2004 Dec; 25(12):2001-3. PubMed ID: 15711685
[TBL] [Abstract][Full Text] [Related]
15. Fetal intravenous immunoglobulin therapy in rhesus hemolytic disease.
Kriplani A; Malhotra Singh B; Mandal K
Gynecol Obstet Invest; 2007; 63(3):176-80. PubMed ID: 17143009
[TBL] [Abstract][Full Text] [Related]
16. Neonatal outcome after fetal anemia managed by intrauterine transfusion.
Garabedian C; Rakza T; Thomas D; Wibaut B; Vaast P; Subtil D; Houfflin-Debarge V
Eur J Pediatr; 2015 Nov; 174(11):1535-9. PubMed ID: 26032762
[TBL] [Abstract][Full Text] [Related]
17. Hyperferritinaemia following intrauterine transfusions for Rh isoimmunisation.
Anne RP; Sundaram V; Dutta S; Kumar P
BMJ Case Rep; 2019 Feb; 12(2):. PubMed ID: 30782626
[TBL] [Abstract][Full Text] [Related]
18. Benefits and risks of fetal red-cell transfusion after 32 weeks gestation.
Klumper FJ; van Kamp IL; Vandenbussche FP; Meerman RH; Oepkes D; Scherjon SA; Eilers PH; Kanhai HH
Eur J Obstet Gynecol Reprod Biol; 2000 Sep; 92(1):91-6. PubMed ID: 10986440
[TBL] [Abstract][Full Text] [Related]
19. Rh hemolytic disease of the newborn.
Page S
Neonatal Netw; 1989 Jun; 7(6):31-41. PubMed ID: 2499756
[No Abstract] [Full Text] [Related]
20. Treatment requirements of infants with rhesus isoimmunisation within a geographically defined area.
Greenough A; Hartnoll G; Hambley H; Richards J
Arch Dis Child Fetal Neonatal Ed; 2002 Nov; 87(3):F202-3. PubMed ID: 12390991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
